# Swiss National Science Foundation

Organization · id `cardio:org-swiss-national-science-foundation` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 00yjd3n13](<https://ror.org/00yjd3n13>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 00yjd3n13 by an exact name.

## The registry's words

- Sponsor name: Swiss National Science Foundation
- Sponsor class: OTHER
- ROR name: Swiss National Science Foundation

## Connected pages

- Sponsors: Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy (`cardio:ct-nct01097967`)
- Sponsors: Controlled Level EVERolimus in Acute Coronary Syndromes (`cardio:ct-nct01529554`)
- Sponsors: Early Sleep Apnea Treatment in Stroke (`cardio:ct-nct02554487`)
- Sponsors: Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function (`cardio:ct-nct03049540`)
- Sponsors: Enhancement of Stroke Rehabilitation With Levodopa (`cardio:ct-nct03735901`)
- Sponsors: MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention (`cardio:ct-nct03961334`)
- Sponsors: Canakinumab in Patients With COVID-19 and Type 2 Diabetes (`cardio:ct-nct04510493`)
- Sponsors: Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation (`cardio:ct-nct05145283`)
- Sponsors: Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure (`cardio:ct-nct06207383`)
- Sponsors: A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation (`cardio:ct-nct07904507`)

## Provenance

Content hash: 4b11ed97ba7b30f35e43310a5544851cc842a527324fbbe570a5d5c47058fb11
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
